Gennex Laboratories Limited (BOM:531739)

Gennex Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	1,521	1,379	867.14	656.03	612.14	596.49
Revenue	1,521	1,379	867.14	656.03	612.14	596.49
Revenue Growth (YoY)	16.04%	59.03%	32.18%	7.17%	2.62%	6.08%
Cost of Revenue	1,089	978.18	493.58	402.92	384.15	359.29
Gross Profit	431.78	400.85	373.57	253.11	227.98	237.2
Selling, General & Admin	93.99	88.01	78.91	80.63	73.48	74.36
Other Operating Expenses	148.93	142.46	120.79	122.77	99.74	96.23
Operating Expenses	263.23	250.37	223.38	212.6	181.1	179.4
Operating Income	168.55	150.48	150.18	40.51	46.88	57.8
Interest Expense	-43.22	-36.08	-30.76	-13.54	-8.77	-7.44
Interest & Investment Income	95.71	95.71	37.95	26.61	9	0.54
Currency Exchange Gain (Loss)	2.39	2.39	1.76	4.15	3.79	3.44
Other Non Operating Income (Expenses)	4.99	1.68	-0	5.5	-0	-
EBT Excluding Unusual Items	228.43	214.18	159.13	63.23	50.9	54.34
Gain (Loss) on Sale of Assets	-0.21	-0.21	5.79	0.5	0.03	-
Other Unusual Items	-3	-	-	-	-	-3.71
Pretax Income	225.22	213.97	164.92	63.73	50.94	50.62
Income Tax Expense	29.75	32.75	33.17	14.52	11.7	10.24
Net Income	191.43	181.23	131.75	49.21	39.23	40.38
Net Income to Common	191.43	181.23	131.75	49.21	39.23	40.38
Net Income Growth	1.58%	37.55%	167.74%	25.43%	-2.85%	117.53%
Shares Outstanding (Basic)	252	227	187	146	127	127
Shares Outstanding (Diluted)	256	231	217	154	127	127
Shares Change (YoY)	3.07%	6.81%	40.48%	21.94%	-	-
EPS (Basic)	0.76	0.80	0.71	0.34	0.31	0.32
EPS (Diluted)	0.75	0.78	0.61	0.32	0.31	0.32
EPS Growth	-1.44%	28.78%	90.60%	2.86%	-2.78%	117.39%
Free Cash Flow	-	-197.44	-466.86	-161.1	103.14	-15.16
Free Cash Flow Per Share	-	-0.85	-2.15	-1.04	0.81	-0.12
Gross Margin	28.39%	29.07%	43.08%	38.58%	37.24%	39.77%
Operating Margin	11.08%	10.91%	17.32%	6.17%	7.66%	9.69%
Profit Margin	12.58%	13.14%	15.19%	7.50%	6.41%	6.77%
Free Cash Flow Margin	-	-14.32%	-53.84%	-24.56%	16.85%	-2.54%
EBITDA	185.63	170.38	173.86	49.7	54.76	66.6
EBITDA Margin	12.20%	12.35%	20.05%	7.58%	8.95%	11.17%
D&A For EBITDA	17.08	19.91	23.68	9.19	7.88	8.81
EBIT	168.55	150.48	150.18	40.51	46.88	57.8
EBIT Margin	11.08%	10.91%	17.32%	6.17%	7.66%	9.69%
Effective Tax Rate	13.21%	15.30%	20.11%	22.79%	22.98%	20.23%
Revenue as Reported	1,629	1,483	916.2	695.56	625.95	601.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.